Development and validation of the Amphetamine-Type Stimulants Motive Questionnaire in a clinical population by Thurn, D. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/177091
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
September 2017 | Volume 8 | Article 1831
Original research
published: 25 September 2017
doi: 10.3389/fpsyt.2017.00183
Frontiers in Psychiatry | www.frontiersin.org
Edited by: 
Luigi Janiri, 
Università Cattolica del Sacro 
Cuore, Italy
Reviewed by: 
Martin Zack, 
Centre for Addiction and 
Mental Health, Canada  
Jane Metrik, 
Brown University, United States
*Correspondence:
Daniela Thurn  
daniela.thurn@uni-bamberg.de
Specialty section: 
This article was submitted to 
Addictive Disorders, 
a section of the journal 
Frontiers in Psychiatry
Received: 12 June 2017
Accepted: 11 September 2017
Published: 25 September 2017
Citation: 
Thurn D, Kuntsche E, Weber JA and 
Wolstein J (2017) Development and 
Validation of the Amphetamine-Type 
Stimulants Motive Questionnaire in 
a Clinical Population. 
Front. Psychiatry 8:183. 
doi: 10.3389/fpsyt.2017.00183
Development and Validation of the 
amphetamine-Type stimulants 
Motive Questionnaire in a clinical 
Population
Daniela Thurn1,2*, Emmanuel Kuntsche3,4,5, Jennifer Anna Weber2 and Jörg Wolstein2
1 Clinical Addiction Medicine, Bezirkskrankenhaus Bayreuth, Bayreuth, Germany, 2 Department of Psychology,  
Otto-Friedrich-University Bamberg, Bamberg, Germany, 3 Centre for Alcohol Policy Research, La Trobe University, 
Melbourne, VIC, Australia, 4 Behavioural Science Institute, Radboud University, Nijmegen, Netherlands, 5 Institute  
of Psychology, Eötvös Loránd University, Budapest, Hungary
Approximately 35.7 million people world-wide use amphetamine-type stimulants (ATS) 
leading to a high demand for effective treatment. Understanding the motives behind 
ATS use is a necessary basis for preventive and therapeutic treatment. The objective 
of this study is to develop the Amphetamine-Type stimulants Motive Questionnaire 
(AMQ) and to confirm its construct and concurrent validity in respect to the first and the 
latest month of ATS use based on answers of 233 patients with ATS disorders (74.2% 
male; mean age: 31.1 years). Confirmatory factor analyses were employed to test for 
the construct validity of the AMQ. Nested models of confirmatory factor analyses with 
increasing constraints for gender and age were estimated to test the equivalence of 
the factor structure in different subgroups. Independent sample t-tests were conducted 
to test for mean differences in the motive dimensions. A structural equation model 
was estimated to confirm the concurrent validity using the latent four motive factors 
(i.e., enhancement, coping, social, and conformity motives) as independent variables 
and frequency of ATS use in the first and the latest month of use as a dependent 
variable. The results confirmed the AMQ’s four-dimensional factor structure in gen-
eral, and across gender and age groups for both periods of time. Men (first month: 
M = 4.21, SD = 0.75; latest month: M = 3.86, SD = 0.93) use ATS more frequently due 
to enhancement motives than women (first month: M = 3.85, SD = 1.12; latest month: 
M = 3.46, SD = 1.29) at both periods of time [first month: t(77) = −2.33, p = 0.022; 
latest month: t(80) = −2.19, p = 0.031]. Structural equation modeling confirmed an 
association between coping motives and use frequency, for both periods of time (first 
and latest month: β = 0.32, p < 0.001), as well as between social motives and fre-
quency of use for the latest month of use (β = 0.30, p < 0.01). To conclude, the AMQ is 
a valid and reliable instrument for assessing motives of ATS use in a clinical population. 
It can provide important insights into the motivational structure of the first and latest 
months of ATS use which are useful for preventive and therapeutic treatments as well 
as the development of abstinence skills.
Keywords: amphetamine-type stimulants, confirmatory factor analysis, motives for aTs use, scale development, 
clinical population
Table 1 | Classification of (drug) consume motives.
Valence
Positive reinforcement negative reinforcement
Source Internal Enhancement motives Coping motives
External Social motives Conformity motives
2
Thurn et al. Amphetamine-Type Stimulants Motive Questionnaire
Frontiers in Psychiatry | www.frontiersin.org September 2017 | Volume 8 | Article 183
inTrODUcTiOn
According to the United Nations Office on Drugs and Crime 
(1), more than 29 million people suffer from drug use disorders. 
Amphetamine-type stimulants (ATS) comprising substances such 
as Speed and Crystal Meth have come into focus due to the high 
potential for drug dependence, cardiovascular and cerebrovas-
cular diseases, infectious diseases or deteriorating dental health, 
as well as cognitive impairments, depression or psychosis (2–6). 
ATS are used by approximately 35.7 million people—second only 
to cannabis with 183 million estimated users, and global seizures 
reached 173 tons of ATS in 2014 (1). ATS use is particularly com-
mon between the ages of 20 and 40 (7, 8) with men being more 
frequently ATS dependent than women (7). Recent research 
has investigated a number of ATS-related issues including the 
illicit use of prescription stimulants (9–11) and the influence of 
expectancies of stimulant use on cognitive enhancement and the 
initiation and maintenance of substance use (12–14). Treatment 
demand has been persistently high since 2003 (1) illustrating the 
need for effective prevention strategies and treatment measures. 
To this end, a profound understanding of the motives for ATS 
use is required. Exploratory studies have made important first 
steps in this direction but have been restricted by small samples 
or qualitative data, making a generalization of the results difficult.
Milin et  al. (15) investigated different motives of ATS use 
in outpatient and inpatient settings, albeit without a theo-
retical basis. They found the motives “I like the effect,” “craving,” 
“enjoying leisure time,” “mood improvement,” and “going out 
despite exhaustion” were the most highly rated. Due to the lack 
of a theoretical model, it however remains difficult to deduce 
clear recommendations for prevention or treatment strategies. 
Further studies dealing with ATS use have provided, amongst 
others, motives such as enhancing sexual performance (15–17), 
improving (cognitive) performance, performing better or 
enhancing the efficiency of an action (10, 17–21) and losing 
weight (15, 17). For persons with attention deficit hyperactivity 
disorder (ADHD), stimulants cause in addition often para-
doxical effects such as calming down and an improved ability 
to focus on activities (22) and can to some extent be regarded 
as negatively reinforcing by reducing stressful effects of their 
activities, tasks and requirements. Other theory-based studies 
investigated use motives based on the Motivational Model of 
Alcohol Use (23, 24) for MDMA use (25) and for substance use 
of psychotic patients (24). To the best of our knowledge, to date 
there are no instruments that assess the motives for ATS use in 
a valid and reliable way which are based on a theoretical model. 
Such an instrument, however, is essential in generating targeted 
preventive and therapeutic treatments (26–28).
The theoretical framework developed in the Motivational 
Model of Alcohol Use (23, 29) is a promising approach for clas-
sifying the motives for ATS use from a theory-guided emotional-
change perspective and laying a foundation for preventative 
and therapeutic treatments. According to this two-dimensional 
model, people display certain behaviors in order to achieve a 
desired affective change (30). This represents the first dimension, 
valence, with positive reinforcement (i.e., to increase positive 
feelings) or negative reinforcement (i.e., to decrease negative 
feelings). The second dimension consists in the source of the 
affective change which can be internal or external. The crossing 
of the two dimensions results in the four broad motive categories 
enhancement, coping, social, and conformity shown in Table 1.
While originally developed for alcohol use, adaptions of 
the Motivational Model were successfully transferred to other 
domains of human functioning such as gambling [GMQ (31)], 
sexual risk-taking behavior (32), Internet use [IMQ-A (33)], and 
listening to music [MLMQ (34)]. In the same vein, this article 
aims to develop a questionnaire to assess motives for using illicit 
ATS—the Amphetamine-type stimulants Motive Questionnaire 
(AMQ).
Based on Cox and Klinger’s Motivational Model (23, 30, 
35), the Drinking Motive Questionnaire Revised (DMQ-R) was 
developed which was later published in a short version [DMQ-R 
SF (36)]. We decided to use the short form of this questionnaire 
as the basis for the development of the AMQ as it performs very 
similarly to the longer version DMQ-R (36, 37) but is more 
viable in a clinical setting. To this end, we adapted the phras-
ing of the 12 items of the DMQ-R SF to ATS use and converted 
them into the first person, e.g., “…because you like the feeling” 
was modified to “…because I like the feeling.” Recent research 
(15, 38) and clinical observations have provided indications for 
differences between motives at the beginning of ATS use and 
after the development of ATS dependence. Therefore, we studied 
the motives in the first and latest month of ATS use unlike other 
studies which usually investigate the motives for other behav-
iors such as alcohol use (32, 36) during the last twelve months. 
However, in both cases the formulation of all items remained the 
same as in the DMQ-R SF.
The following hypotheses were tested: (a) For both periods 
of time, we predicted a good fit of the AMQ four-factor model 
and high factor loadings of the corresponding items, and at least 
satisfactory internal consistencies, which provide evidence for 
construct validity (39, 40). (b) We also predicted, for both periods 
of time, equivalence of the factor structure among subgroups (gen-
der and age) in respect to the four-dimensional factor structure 
of the AMQ which is a pre-requirement for group comparisons. 
(c) Furthermore, we tested mean differences in the subgroups 
gender and age in the four factors for both periods of time. Based 
on previous research (38), we expected a higher level of coping 
motives for women than men. Moreover, we also explored age 
differences in ATS use motives (due to non-existing evidence in 
previous studies). (d) Finally, we estimated a multivariate struc-
tural equation model to confirm the concurrent validity. Clinical 
observations and results in the field of alcohol and cannabis use 
motives (24) have suggested that the use frequency of ATS use 
(for the first and the latest month of use) is associated with coping 
and enhancement motives.
Table 2 | Item factor loadings, item means, inter-factor correlations and internal consistencies as results of the confirmatory factor analysis to test the four-factor 
structure (first month of use/latest month of use).
enhancement coping social conformity Means (sD)
“I used my main drug in the first month vs. in the latest month of use …”
First month/latest month of use
Because I like the feeling 0.61/0.83 4.47 (0.90)/3.97 (1.20)
To get high 0.76/0.54 3.71 (1.28)/3.93 (1.29)
Because it’s fun 0.83/0.79 4.20 (1.03)/3.40 (1.41)
Because it helps when I feel depressed or nervous 0.76/0.76 3.15 (1.33)/3.70 (1.30)
To cheer up when I am in a bad mood 0.75/0.84 3.33 (1.27)/3.82 (1.20)
To forget about my problems 0.73/0.79 3.19 (1.45)/3.85 (1.33)
Because it helps me to enjoy a party 0.81/0.87 3.62 (1.30)/2.57 (1.48)
Because it makes social gatherings more fun 0.48/0.63 3.63 (1.28)/2.90 (1.43)
Because it improves parties and celebrations 0.95/0.88 3.50 (1.37)/2.65 (1.43)
To be liked 0.84/0.78 2.02 (1.20)/1.63 (1.00)
To fit in with a group I like 0.71/0.75 1.91 (1.25)/1.42 (0.83)
So I won’t feel left out 0.85/0.63 1.96 (1.20)/1.75 (1.15)
Correlation with the factor “Coping” 0.16/0.36*
Correlation with the factor “Social” 0.50*/0.57* 0.06/0.19*
Correlation with the factor “Conformity” 0.11/0.19* 0.17*/0.18* 0.19*/0.29*
Internal consistencies (Cronbach’s α) 0.72/0.72 0.79/0.79 0.78/0.84 0.85/0.75
Standardized factor loadings that are all significant at the 0.001% error level; model fit: (a) first month of use: CFI = 0.945; TLI = 0.907; RMSEA = 0.071; (b) latest month of use: 
CFI = 0.940; TLI = 0.898; RMSEA = 0.077.
*p < 0.05.
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MaTerials anD MeThODs
study Design
We collected data from individuals with ATS disorders who 
presented as outpatients at drug counseling centers or as inpa-
tients in hospital based drug treatment programs. Of the 133, 11 
contacted drug-counseling centers (participation rate: 8.3%), 1 of 
the 13 contacted cessation therapy clinics specialized in crystal 
meth addiction (participation rate: 7.7%), 2 contacted addiction 
departments, and 1 forensic department of Regional Psychiatric 
Hospitals took part in the study. The Ethics Council of the 
University of Bamberg granted permission to conduct the study 
(July 28, 2014/June 06, 2016).
Only patients who were primarily addicted to illicit ATS were 
asked whether they were interested in participating in the study. 
The patients were briefed on the goals and contents and were 
informed about their right to withdraw from the study at any time. 
Participation was voluntary for all patients and anonymity was 
guaranteed. The participants were asked to complete question-
naires on their ATS use motives (AMQ), patterns of ATS use and 
demographic data. All outpatients received a 5€ remuneration for 
taking part in the study. The data were collected between January 
2015 and July 2016.
sample and Missing Values
The original sample consisted of 248 individuals with ATS dis-
orders. Participants who did not use ATS as their primary drug 
of choice (N = 8, 3.2%) were excluded as were those who failed 
to answer more than half of the questions on ATS use motives 
(N = 6, 2.4%) and one participant who took part in the study on 
two occasions (0.4%). The remaining data included 233 partici-
pants. There were no missing values on gender or age. The full 
information maximum likelihood (FIML) option of the statisti-
cal software AMOS (41) was used to account for the remaining 
missing values (up to 2.1% per item). The analyzed data consisted 
of 173 men (74.2%) and 60 women (25.8%). The mean age was 
31.1 years (SD = 7.9; age range 18–54). Drug counseling centers 
provided 113 data sets (48.5%), 49 data sets (21.0%) were provided 
by addiction departments of Regional Psychiatric Hospitals, 
43 (18.5%) by a cessation therapy clinic, and 28 (12.0%) by a 
forensic department of a Regional Psychiatric Hospital.
Measures
The 12 motive items in the AMQ were adapted from the DMQ-R 
SF (36) with 3 items per dimension (enhancement, social, coping, 
and conformity). As the use motives seem to differ between the 
beginning of ATS use and, e.g., after the development of an ATS 
addiction (15, 38) the participants were asked to specify how 
often they used ATS for two periods of time: in their first month 
of use and their latest month of use. Possible answers were “never” 
(coded as 1), “seldom” (coded as 2), “sometimes” (coded as 3), 
“most of the time” (coded as 4), and “always” (coded as 5). The 
phrasing of all items is given in Table 2.
The patient questionnaire is based on the “Deutscher 
Kerndatensatz Klienten (KDS-K) zur Dokumentation im Bereich 
der Suchtkrankenhilfe” (German core data set of clients for docu-
mentation in the field of addiction treatment) (42) which has been 
applied in German drug-counseling centers and in inpatient drug 
treatment centers since 2007. It provides, amongst others, informa-
tion about the age, gender (1 = female, 2 = male) and frequency 
of use in the first and the latest month of use, coded as monthly 
frequency, i.e., several times a day = 60, once a day = 30, three to six 
times a week = 19, one to two times a week = 6, two to three times 
a month = 3, once a month = 1, and less than once a month = 0.
Table 3 | Model fit according to gender and age (first month of use and latest month of use).
χ2 df cFi Tli rMsea
First month/latest month of use
gender (men vs. women)
Unconstrained model 140.2/150.2 92 0.949/0.944 0.914/0.906 0.048/0.052
λ-Constrained model 154.1/170.6 100 0.943/0.933 0.911/0.895 0.048/0.055
Plus variance constrained 162.9/184.5 104 0.938/0.923 0.907/0.885 0.050/0.058
Plus correlations constrained 168.1/195.9 110 0.939/0.918 0.913/0.884 0.048/0.058
age groups (≤30 vs. >30 years)
Unconstrained model 140.5/160.5 92 0.951/0.935 0.916/0.890 0.048/0.057
λ-Constrained model 157.1/176.4 100 0.942/0.928 0.909/0.888 0.050/0.058
Plus variance constrained 161.7/179.2 104 0.941/0.929 0.912/0.893 0.049/0.056
Plus correlations constrained 174.0/186.7 110 0.935/0.928 0.908/0.897 0.050/0.055
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statistical analysis
We used confirmatory factor analysis (CFA) estimated in statisti-
cal software SPSS (AMOS Version 23), in order to confirm the 
assumed four-factor structure of the AMQ (a) for ATS use in the 
first month and ATS use in the latest month, separately. Since 
the formulation of two item pairs was more similar than the third 
item used to constitute a given latent factor (e.g., the two items 
“to get high” and “because it’s fun” as enhancement motives) the 
errors of the two item pairs were allowed to correlate as to com-
pensate answer tendencies (43). We used the Comparative Fit 
Index (CFI), the Trucker Lewis Index (TLI), and the Root Mean 
Square Error of Approximation (RMSEA) to assess the model 
fit. The CFI and TLI compare the tested model with a null or 
independent model; recommended thresholds for a good model 
fit are a CFI and a TLI of ≥0.95 (44). The RMSEA represents 
the mean deviation of the data from the model per degree of 
freedom. A RMSEA of <0.1 (44) is desirable. To evaluate the 
internal consistencies of the AMQ, we used Cronbach’s Alpha. 
Values of 0.7 are considered as satisfactory, of 0.8 as good and of 
0.9 as excellent (40).
To test the equivalence of the factor structure in different sub-
groups (b), we estimated nested models of confirmatory factor 
analyses with increasing constraints for gender and age (median 
split: younger users up to 30 years vs. older users over 30 years). 
First, we tested the configural invariance for the grouping variables 
gender and age which is supported if the unconstrained model 
has an acceptable fit to the data. Second, we tested the metric 
invariance for the grouping variables which requires equivalent 
factor loadings between the groups (λ-constrained model). 
Furthermore, we analyzed whether the fit indices remained 
equivalent when we constrained the variances in addition to the 
factor loadings (third model) and, finally, when we constrained 
the factor loadings, the variances and the correlations between 
the groups (fourth model) (43, 45). We compared the CFI, the 
TLI and the RMSEA of the fixed models with the fit indices of the 
freely estimated models.
Furthermore, independent sample t-tests conducted in SPSS 
23 were used to test mean differences in the motive dimensions 
(c) between the gender and age subgroups. Therefore, we com-
puted mean scores for the four motive dimensions.
To confirm the concurrent validity (d), we estimated a 
structural equation model with the latent four motive factors as 
independent variables and the ATS use frequencies of the first 
and the latest months of use as dependent variables. All analyses 
were conducted with SPSS AMOS Version 23 (41) by using the 
FIML option of AMOS.
resUlTs
confirming construct Validity of the aMQ
For the first month of ATS use, the CFA provided highly sig-
nificant factor loadings reaching from 0.48 to 0.95 (all p < 0.001; 
Table 2). The social factor had the lowest and the highest item 
loadings. The conformity factor had consistently high item load-
ings from λ = 0.71 to λ = 0.85 with an internal consistency of 
0.85. All other internal consistencies were 0.72 or higher. Except 
between enhancement and social, all interfactor correlations were 
smaller than 0.20. There was a good fit to the data with a CFI of 
0.945, a TLI of 0.907, and a RMSEA of 0.071.
The CFA of the latest month of use also provided highly 
significant factor loadings (all p  <  0.001; Table  2) reaching 
from 0.54 to 0.88. The enhancement factor had the lowest item 
loading (λ = 0.54) with an internal consistency of α = 0.72. The 
highest item loading was found on the social factor (0.88), its 
internal consistency was α = 0.84. As in the first month of use, 
we observed the highest correlation between the enhancement 
and the social factor; all others were smaller. There was a good 
fit to the data with a CFI of 0.940, a TLI of 0.898 and a RMSEA 
of 0.077.
Testing construct Validity in Different 
subgroups
In order to test the four-factor structure of the four-factor model 
according to gender and age groups, we performed nested 
models of confirmatory factor analyses with increasing degrees 
of freedom for the subgroups. For the first month of ATS use 
configural invariance was given for all subgroups (unconstrained 
models) with CFI and TLI values above 0.9 and RMSEA below 0.1 
(Table 3). Metric invariance was also given as the model fit only 
differs slightly between the unconstrained and λ-constrained 
models. Furthermore, the fit indices in the two subgroups did 
not change considerably when we constrained the factor loadings 
and variances (third model), or the factor loadings, variances and 
Table 4 | Means (SDs in brackets) of the four motive dimensions according to gender and age group and independent sample t-tests (first month and latest month of 
use).
enhancement coping social conformity
First month/latest month of use
gender
Women 3.85 (1.12)/3.46 (1.29) 3.40 (1.20)/3.79 (1.28) 3.40 (1.11)/2.52 (1.19) 1.99 (1.18)/1.50 (0.77)
Men 4.21 (0.75)/3.86 (0.93) 3.17 (1.12)/3.79 (1.04) 3.64 (1.10)/2.77 (1.21) 1.95 (1.02)/1.64 (0.83)
t Value −2.33*/−2.19* 1.32/0.01 −1.44/−1.41 0.29/−1.14
age group
≤30 years 4.17 (0.91)/3.87 (1.06) 3.21 (1.22)/3.89 (1.10) 3.67 (1.05)/2.79 (1.23) 2.02 (1.10)/1.60 (0.78)
>30 years 4.06 (0.84)/3.64 (1.02) 3.25 (1.05)/3.69 (1.11) 3.48 (1.15)/2.62 (1.19) 1.90 (1.02)/1.60 (0.85)
t Value 0.86/1.66 −0.24/1.35 1.33/1.08 0.83/−0.03
Total 4.12 (0.87)/3.76 (1.04) 3.23 (1.14)/3.79 (1.11) 3.58 (1.10)/2.70 (1.21) 1.96 (1.06)/1.60 (0.82)
*p < 0.05.
Table 5 | ATS use frequency (standardized regression coefficients and explained variance).
enhancement coping social conformity R2
First month/latest month of use
Use frequency 0.10/−0.14 0.32***/0.32*** 0.03/0.30** −0.02/−0.02 12.6/15.6%
***p < 0.001; **p < 0.01; model fit for the first month of ATS use: CFI = 0.945; TLI = 0.908; RMSEA = 0.066. Model fit for the latest month of ATS use: CFI = 0.936; TLI = 0.893; 
RMSEA = 0.074.
5
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correlations (fourth model). All CFI and TLI values were above 
0.9 and all RMSEA values below 0.1.
For the latest month of ATS use, configural invariance was 
given in the unconstrained model for the subgroup gender with 
CFI and TLI values above 0.9 and RMSEA below 0.1 and almost 
given for the subgroup age with a CFI value of 0.935, a TLI 
value of 0.890, and RMSEA below 0.1. All other tested models 
(λ-constrained model, plus variance constrained model, and plus 
correlations constrained model) displayed similar CFI values 
above 0.9, TLI values very close to 0.9, and RMSEA values below 
0.1 in both subgroups gender and age (Table 3).
The results basically remained the same when the sample was 
split at age 25 and 35, respectively. The resulting model fit indices 
can be obtained from the authors on request.
Testing Mean Differences between the 
subgroups
In the first month of ATS use, men scored higher on positive rein-
forcement (enhancement and social motives). However, this dif-
ference was only significant for enhancement motives (Table 4). 
Women scored somewhat higher on negative reinforcement 
(coping and conformity motives) but the differences were not 
statistically significant. The subgroup age revealed no significant 
differences in the four motive dimensions. Younger ATS users 
scored slightly higher on enhancement, social, and conformity 
motives and lower in coping motives than older ATS users but 
none of these differences were significant.
In the latest month of use, men scored higher on positive rein-
forcement (enhancement and social motives) and on conformity 
motives with a significant difference in enhancement motives 
(Table 4). Women and men scored identically on coping motives. 
Also for the latest month of ATS use, the subgroup age revealed 
no significant differences in the four motive dimensions.
confirming concurrent Validity of the aMQ
The estimation of the structural equation model revealed that 
higher coping motives are connected with higher frequency 
of ATS use for the first and the latest month of ATS use. A 
further positive association was found between social motives 
and frequency of ATS use for the latest month of use (Table 5). 
The explained variance was 12.6 and 15.6% for the first and the 
latest month of ATS use, respectively. In a final step, the link 
between the four motive factors and frequency of ATS use was 
adjusted for gender and age effects. However, the results (not 
shown but available from the authors on request) remained 
basically unchanged due to non-significant gender and age 
effects.
DiscUssiOn
The aim of this study was to develop the four-dimensional AMQ 
and to validate it with regards to the first month and the latest 
month of ATS use. It was expected that the AMQ and its underly-
ing theoretical considerations are valid for both periods of time 
which was formally tested in this article.
The first aim (a) was to test construct validity (39) by means 
of CFA which revealed good model fit according to the CFI and 
the RMSEA values and acceptable model fit according to the TLI 
values for the hypothesized four-factor model for motives of 
ATS use. The values for the recall of the first month of ATS use 
were consistently slightly higher in terms of factor loadings of 
the corresponding items which means that the data gathered for 
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the first period of time was slightly better approximated by the 
four-factor model. The highest interfactor correlation was found 
between social and enhancement for both periods of time with 
slightly higher values for the recall of the latest month of use. 
This indicates that those who used ATS for instance “because 
it is fun” also tended to use it because it improves parties and 
celebrations. This relation may become even more important 
over time. A strong link between enhancement and social 
motives was also found for alcohol use (32, 36) and listening to 
music (34). Furthermore, consistent with previous research on 
other domains of human functioning, high internal consistencies 
were found for both periods of time (40) which is particularly 
remarkable considering only three items were used to measure 
each factor.
Second (b), the CFA in the subgroups demonstrated the 
equivalence of the four-dimensional factor structure of the AMQ 
across gender and age. This not only indicates that the theoretical 
assumptions held true in both subgroups but also that the AMQ 
can be used to compare both subgroups. Based on the different 
scores in the motive dimensions, subgroup-specific interventions 
may be deduced for clinical practice.
The analysis of mean differences across subgroups (c) 
revealed that men use ATS more frequently due to enhance-
ment motives than women. This was true for both periods of 
time. A possible explanation is that men are generally more 
open to new experiences, seek extreme sensations, and are 
more willing to experience adverse consequences (46, 47). No 
gender-specific differences were observed at either period of 
time in any other motive dimension. The expected differences 
in the coping dimension could not be confirmed, which may be 
explained by the fact that our study includes a different selec-
tion of items than the cited study (38). There were no significant 
age differences in the four motive dimensions for either period 
of time. Therefore, motive based therapies may be applied to a 
wide age range.
The questionnaire was found to have concurrent validity (d) 
as the structural equation model revealed a significant positive 
relation between coping motives and frequency of use in the first 
and latest month of ATS use, i.e., those who used ATS to cope 
used them more frequently. This is to some extent consistent with 
previous research (24) in which the frequency of ATS use was 
associated with coping and enhancement motives and underlines 
the vicious circle in which patients with ATS disorders often end 
up: coping with problems caused by using ATS leads to further 
ATS use. Furthermore, there was a significant positive relation 
between social motives and frequency of use in the latest month 
of ATS use, i.e., those who used ATS for social reasons in this 
time period used them more frequently. This may be related to 
the circle of acquaintances the users have built and with whom 
they party regularly.
limitations and recommendations for 
Future research
Since the study relies on the retrospective recall of use motives, 
memory bias constitutes an important limitation (48) which 
may partly explain the sufficient but not optimal model fit. 
The sample consisted of a heterogeneous group of patients 
which differed in the length of their abstinence: some presented 
themselves at drug counseling centers and were not abstinent 
at that time, some were in cessation therapy clinics and were 
abstinent from 0 to 6  months and others again were in the 
forensic department of a Regional Psychiatric Hospital and 
were abstinent from a few months to a few years. Depending on 
the recency of their last ATS use (49–51) and history of treat-
ments (52), patients had different opportunities to deal with 
their relapses, to develop abstinence skills and to reflect on their 
motives of ATS use. Particularly the latter aspect may have had 
an effect on the answers given in the questionnaire. While mean 
levels of motive endorsement may be subject to recall bias, the 
four-factor classification of motives according to the valence 
and the source is not affected as studies in the field of alcohol 
use have shown (37, 45). We, thus, consider the recall bias as 
reasonable trade-off between feasibility of data collection and 
accuracy. In addition, some important aspects in the field of ATS 
use had not been considered in the 12-item AMQ: individuals 
with ATS disorders reported using ATS to improve sex (15–17), 
to enhance their cognitive performance (10, 17–21), to lose 
weight (17), to be able to stay awake, and as a self-medication 
(22) for symptoms of ADHD. Although the aforementioned 
reasons seem to be less common compared to items in the AMQ 
such as getting high or having fun (17), further studies should 
examine the importance of other amphetamine-specific motives 
of ATS use. Considering the intricate circumstances in this 
clinical setting—e.g., approaching ATS users and convincing 
therapists of the advantages of participating in the study—the 
sample size of 233 people can be regarded as sufficient. Larger 
sizes of clinical samples are difficult to achieve. This becomes 
apparent in the generally low response rates reported in the 
study design section which may have had an effect on the results. 
Moreover, it should be examined whether the AMQ, which was 
developed and validated in this study using a clinical sample in 
Southern Germany, can also be applied to non-clinical samples 
and in other countries. It would also be worthwhile to apply the 
AMQ to primary substances like illicit prescription stimulants 
or MDMA and related drugs. Furthermore, longitudinal studies 
are needed to be able to prospectively evaluate the development 
of ATS motives over time. Finally, we recommend including 
additional outcome variables in future research to extend the 
concurrent validity of the AMQ.
conclusion
The application of the Motivational Model of Alcohol Use (23, 29) 
to ATS use is an important step toward a better understanding 
of why people use ATS particularly since most use the substance 
in spite of knowing the high potential for dependence and the 
multiple somatic and mental consequences (2–6). Moreover, as a 
theory-based instrument, the AMQ closes a gap in ATS research 
and may assist in generating targeted preventive and therapeutic 
treatments (26–28) as it can reveal recalled former and current 
motives of ATS use. For the assessment of use motives of patients, 
the AMQ can help understand why people begin and continue to 
use ATS and in a second step to personalize the treatment which 
has to manage the resulting changes related to ATS abstinence 
7Thurn et al. Amphetamine-Type Stimulants Motive Questionnaire
Frontiers in Psychiatry | www.frontiersin.org September 2017 | Volume 8 | Article 183
(17). In this study, the AMQ was shown to be succinct and viable 
in a clinical setting and has demonstrated its construct validity 
and reliability. It also constitutes a basis for future research, in 
particular to study changes in the motive structure between the 
first and latest month of ATS use.
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